NovAccess Global Inc. (OTCMKTS:XSNX) Sees Large Drop in Short Interest

NovAccess Global Inc. (OTCMKTS:XSNX) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 3,400 shares, a decrease of 37.0% from the September 15th total of 5,400 shares. Based on an average daily trading volume, of 73,100 shares, the days-to-cover ratio is presently 0.0 days.

NovAccess Global Stock Performance

OTCMKTS:XSNX opened at $0.01 on Friday. The company has a market capitalization of $269,830.00, a PE ratio of -0.05 and a beta of 1.82. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. NovAccess Global has a fifty-two week low of $0.00 and a fifty-two week high of $0.07.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.